Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach.
Overview
- Morphoscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
- Anatomic Pathology Department, Biopathology laboratory, Clinical Research Center, University Hospital Mohammed VI, Marrakech, Morocco
- Biological Engineering Laboratory, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni Mellal 23000, Morocco
- Genetics department, Clinical Research Center, University Hospital Mohammed VI, Marrakech, Morocco
- Research Center for Childhood, Health and Sustainable Development, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
- Histology, Embryology and Cytogenetics Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GPL570, at NCBI GEO; found in the text, “Hub genes validation”
- rcsb.org/
structure/ , at PDB; found in the resources tablehttps:
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Hub genes validation”
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 5 keywords, 50 references.
Cite
This paper
Anass, O., Youssef, N., El mostafa, S., Khalid, J., Basma, Z., Souad, S., & Hanane, R. (2026). Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach. Journal, genetic engineering & biotechnology, 24(3), 100724. https://
BibTeX
@article{anass2026invest
author = {Anass, Oukhdouch and Youssef, Nadir and El mostafa, Salman and Khalid, Jebhi and Basma, Zinbi and Souad, Sellami and Hanane, Rais},
title = {{Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach}},
journal = {Journal, genetic engineering \& biotechnology},
year = {2026},
month = jun,
volume = {24},
number = {3},
pages = {100724},
publisher = {Academy of Scientific Research and Technology, Egypt},
issn = {1687-157X},
doi = {10.1016/
url = {https://
pmid = {42749405},
pmcid = {PMC13311168}
}
RIS
TY - JOUR
AU - Anass, Oukhdouch
AU - Youssef, Nadir
AU - El mostafa, Salman
AU - Khalid, Jebhi
AU - Basma, Zinbi
AU - Souad, Sellami
AU - Hanane, Rais
TI - Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach
T2 - Journal, genetic engineering & biotechnology
J2 - J Genet Eng Biotechnol
PY - 2026
DA - 2026/
VL - 24
IS - 3
SP - 100724
SN - 1687-157X
PB - Academy of Scientific Research and Technology, Egypt
DO - 10.1016/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1016/
"type": "article-journal",
"title": "Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach",
"container-title": "Journal, genetic engineering & biotechnology",
"author": [
{
"family": "Anass",
"given": "Oukhdouch"
},
{
"family": "Youssef",
"given": "Nadir"
},
{
"family": "El mostafa",
"given": "Salman"
},
{
"family": "Khalid",
"given": "Jebhi"
},
{
"family": "Basma",
"given": "Zinbi"
},
{
"family": "Souad",
"given": "Sellami"
},
{
"family": "Hanane",
"given": "Rais"
}
],
"container-title-short":
"volume": "24",
"issue": "3",
"page": "100724",
"DOI": "10.1016/
"PMID": "42749405",
"PMCID": "PMC13311168",
"ISSN": "1687-157X",
"publisher": "Academy of Scientific Research and Technology, Egypt",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
17
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1016/j.isci.2022.104398
- AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma.Journal: iScienceIn common: other condition, cellular / molecular, 4 references
- [2] doi:10.32604/or.2026.079221
- Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.Journal: Oncology researchIn common: other condition, cellular / molecular, 5 references
- [3] doi:10.3389/fimmu.2023.1238684
- The unique immune ecosystems in pediatric brain tumors: integrating single-cell and bulk RNA-sequencing.Journal: Frontiers in immunologyIn common: NCBI GEO GPL570, other condition, cellular / molecular, 1 reference
- [4] doi:10.3390/biomedicines11123168
- Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma.Journal: BiomedicinesIn common: NCBI GEO GPL570, other condition, 1 reference
- [5] doi:10.1007/s12672-025-03390-6
- EGFR gene amplification in IDH-wildtype glioblastomas: an integrative bioinformatic and histopathological analysis using immunohistochemistry and fluorescence in situ hybridization.Journal: Discover oncologyIn common: NCBI GEO GPL570, other condition, 1 reference
- [6] doi:10.1038/s41598-024-79391-2
- Discovery of key molecular signatures for diagnosis and therapies of glioblastoma by combining supervised and unsupervised learning approaches.Journal: Scientific reportsIn common: other condition, cellular / molecular, 3 references
- [7] doi:10.3389/fgene.2024.1356611 [code]
- Cellular diversity through space and time: adding new dimensions to GBM therapeutic development.Journal: Frontiers in geneticsIn common: other condition, cellular / molecular, 4 references
- [8] doi:10.1093/neuonc/noaf026 [code]
- GBMPurity: A machine learning tool for estimating glioblastoma tumor purity from bulk RNA-sequencing data.Journal: Neuro-oncologyIn common: other condition, 4 references
- [9] doi:10.1186/s10020-023-00652-3
- CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.Journal: Molecular medicine (Cambridge, Mass.)In common: NCBI GEO GPL570, other condition, cellular / molecular
- [10] doi:10.1016/j.ebiom.2022.104239
- Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM.Journal: EBioMedicineIn common: other condition, cellular / molecular, 4 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
